ArticleFrontiers in oncology2022

Effectiveness of TKI Inhibitors Combined With PD-1 in Patients With Postoperative Early Recurrence of HCC: A Real-World Study.

Zixiong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.